www.investorcalendar.com/IC/CEPage.asp?ID=175761 or http://www.tenaxthera.com

A webcast replay will be available for three months, beginning approximately 2 hours after the completion of the live event.

About Tenax Therapeutics

Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The Company owns the North American rights to develop and commercialize levosimendan, a novel, first in class calcium sensitizer/K-ATP activator. For more information, visit www.tenaxthera.com.

SOURCE: Investor Network

ReleaseID: 457737

"/> Investor Network Invites You to the Tenax Therapeutics Fiscal Year 2016 Business Review and Update Conference Call and Webcast on Tuesday, March 21, 2017 « MarketersMedia – Press Release Distribution Services – News Release Distribution Services

Investor Network Invites You to the Tenax Therapeutics Fiscal Year 2016 Business Review and Update Conference Call and Webcast on Tuesday, March 21, 2017

MORRISVILLE, NC / ACCESSWIRE / March 20, 2017 / Tenax Therapeutics, Inc. (NASDAQ: TENX) will host a conference call and webcast to discuss the results of the fiscal year 2016, to be held Tuesday, March 21, 2017 at 8:30 AM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

Date, Time: March 21, 2017 at 8:30 AM ET
Toll Free: (866) 682-6100
International: (862) 255-5401
Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175761 or http://www.tenaxthera.com

A webcast replay will be available for three months, beginning approximately 2 hours after the completion of the live event.

About Tenax Therapeutics

Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The Company owns the North American rights to develop and commercialize levosimendan, a novel, first in class calcium sensitizer/K-ATP activator. For more information, visit www.tenaxthera.com.

SOURCE: Investor Network

ReleaseID: 457737

MORRISVILLE, NC / ACCESSWIRE / March 20, 2017 / Tenax Therapeutics, Inc. (NASDAQ: TENX) will host a conference call and webcast to discuss the results of the fiscal year 2016, to be held Tuesday, March 21, 2017 at 8:30 AM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

Date, Time: March 21, 2017 at 8:30 AM ET
Toll Free: (866) 682-6100
International: (862) 255-5401
Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175761 or http://www.tenaxthera.com

A webcast replay will be available for three months, beginning approximately 2 hours after the completion of the live event.

About Tenax Therapeutics

Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The Company owns the North American rights to develop and commercialize levosimendan, a novel, first in class calcium sensitizer/K-ATP activator. For more information, visit www.tenaxthera.com.

SOURCE: Investor Network

ReleaseID: 457737

Source URL: https://marketersmedia.com/investor-network-invites-you-to-the-tenax-therapeutics-fiscal-year-2016-business-review-and-update-conference-call-and-webcast-on-tuesday-march-21-2017/179517

Source: AccessWire

Release ID: 179517


Latest News